+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07895511

Evaluating the Safety of Omitting Radiation Therapy After Lumpectomy in Low-risk HER2-positive Breast Cancer Patients Receiving HER2-targeted Therapy

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-10-29

136

Participants Needed

7

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether it is safe to skip radiation therapy to the breast after lumpectomy in people with low-risk HER2-positive breast cancer who are receiving HER2-targeted therapy. This study focuses on patients who have received breast conserving surgery and systemic HER2-targeted treatment. The goal is to determine the rate of cancer recurrence in the same breast over a 5-year period without radiation therapy. Participants will continue standard HER2-targeted therapy as part of their usual care and may also receive endocrine therapy if their cancer is hormone receptor-positive. Radiation therapy to the breast will be omitted after lumpectomy. The study includes patients who have completed neoadjuvant or adjuvant systemic therapy within 90 days before enrollment and meet specific tumor size and nodal evaluation criteria. During the study, participants will be monitored for cancer recurrence in the treated breast over 5 years. Researchers will evaluate safety and recurrence rates without radiation, following tumor and nodal status according to established guidelines. Participants will have imaging such as mammograms or MRIs within 52 weeks prior to enrollment and will be regularly assessed as part of their ongoing care throughout the study period.

CONDITIONS

Brief Title

A Study of Skipping Radiation Therapy in People With Breast Cancer

Research Team

L

Lior Braunstein, MD

D

Diana Roth O'Brien, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here